DK1767639T3 - Orale anti-leucocytozoonose-vacciner på basis af transgeniske planter - Google Patents

Orale anti-leucocytozoonose-vacciner på basis af transgeniske planter

Info

Publication number
DK1767639T3
DK1767639T3 DK05743390.6T DK05743390T DK1767639T3 DK 1767639 T3 DK1767639 T3 DK 1767639T3 DK 05743390 T DK05743390 T DK 05743390T DK 1767639 T3 DK1767639 T3 DK 1767639T3
Authority
DK
Denmark
Prior art keywords
leucocytozoonosis
transgenic plants
vaccines based
oral anti
chickens
Prior art date
Application number
DK05743390.6T
Other languages
English (en)
Inventor
Akira Ito
Toru Gotanda
Shigeki Kobayashi
Katsumi Kume
Takeshi Matsumura
Original Assignee
Kitasato Daiichi Sankyo Vaccine Co Ltd
Nat Inst Of Advanced Ind Scien
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kitasato Daiichi Sankyo Vaccine Co Ltd, Nat Inst Of Advanced Ind Scien filed Critical Kitasato Daiichi Sankyo Vaccine Co Ltd
Application granted granted Critical
Publication of DK1767639T3 publication Critical patent/DK1767639T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A61P33/12—Schistosomicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C12N15/8258—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon for the production of oral vaccines (antigens) or immunoglobulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
DK05743390.6T 2004-05-31 2005-05-30 Orale anti-leucocytozoonose-vacciner på basis af transgeniske planter DK1767639T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004160666 2004-05-31
PCT/JP2005/009851 WO2005116216A1 (ja) 2004-05-31 2005-05-30 遺伝子組換え植物による抗原虫病経口ワクチン

Publications (1)

Publication Number Publication Date
DK1767639T3 true DK1767639T3 (da) 2012-06-11

Family

ID=35450895

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05743390.6T DK1767639T3 (da) 2004-05-31 2005-05-30 Orale anti-leucocytozoonose-vacciner på basis af transgeniske planter

Country Status (8)

Country Link
US (1) US8617575B2 (da)
EP (1) EP1767639B1 (da)
JP (1) JP4898432B2 (da)
AT (1) ATE547526T1 (da)
AU (1) AU2005248233C1 (da)
CA (1) CA2567952C (da)
DK (1) DK1767639T3 (da)
WO (1) WO2005116216A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110195091A1 (en) 2008-08-18 2011-08-11 The Kitasato Institute Avian Influenza Virus Antigen, and Booster Immunization Method for Avian Influenza Vaccine in Combination with Mucosal Adjuvant Which is Effective Through Oral Administration
JP5685086B2 (ja) * 2009-01-29 2015-03-18 ホクサン株式会社 アディポネクチンを含有する経口用摂食調整剤
US10154974B1 (en) 2015-10-16 2018-12-18 The Regents Of The University Of California Use of abscisic acid for the prevention and treatment of malaria
EP3508216A4 (en) * 2016-09-05 2020-05-13 Hokusan Co. Ltd. VACCINE BLOCKING THE SPREAD OF MALARIA
CN110684097B (zh) * 2019-09-02 2023-11-10 佛山市正典生物技术有限公司 卡氏住白细胞虫重组r7蛋白及其制备方法和应用
CN110596400B (zh) * 2019-09-02 2023-04-07 佛山市正典生物技术有限公司 基于卡氏住白细胞虫重组r7蛋白的间接elisa检测方法及应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990002484A1 (en) 1988-09-06 1990-03-22 Washington University Oral immunization by transgenic plants
US20020006411A1 (en) * 1991-08-26 2002-01-17 Arntzen Charles Joel Vaccines expressed in plants
GB9403819D0 (en) * 1994-02-28 1994-04-20 Univ Leeds Control of parasites
JP3582663B2 (ja) * 1994-04-19 2004-10-27 社団法人日本動物用医薬品協会 鶏ロイコチトゾーン免疫原性蛋白質を発現する遺伝子クローン及び鶏ロイコチトゾーン症に対する遺伝子組換えワクチン
EP0793717B1 (en) 1994-10-24 2005-01-26 The Texas A & M University System Oral immunization with transgenic plants
WO1996040229A1 (en) * 1995-06-07 1996-12-19 Thomas Jefferson University Vaccines synthesized by transgenic plants
CN1191357C (zh) 1998-12-22 2005-03-02 博伊斯·汤普生植物研究所 口服的免疫原性细菌肠毒素在转基因植物中的表达
ATE478150T1 (de) * 1999-10-26 2010-09-15 Stichting Dienst Landbouwkundi Säugetierartige glykosylierung in pflanzen
JP4501801B2 (ja) 2005-07-15 2010-07-14 株式会社デンソーウェーブ 光学的情報読取装置

Also Published As

Publication number Publication date
CA2567952A1 (en) 2005-12-08
US20080003243A1 (en) 2008-01-03
EP1767639A4 (en) 2008-03-05
AU2005248233B2 (en) 2010-02-18
JPWO2005116216A1 (ja) 2008-04-03
CA2567952C (en) 2016-02-02
ATE547526T1 (de) 2012-03-15
EP1767639B1 (en) 2012-02-29
WO2005116216A1 (ja) 2005-12-08
EP1767639A1 (en) 2007-03-28
AU2005248233B8 (en) 2010-04-01
AU2005248233A1 (en) 2005-12-08
JP4898432B2 (ja) 2012-03-14
AU2005248233C1 (en) 2010-08-19
US8617575B2 (en) 2013-12-31

Similar Documents

Publication Publication Date Title
Meyer et al. Human and bovine respiratory syncytial virus vaccine research and development
EP1924282A4 (en) IMMUNIZATION OF AVIANES BY ADMINISTRATION OF NON-REPLICATED VACCINES
DK2097102T3 (da) Kombinationsvaccine med reducerede mængder af poliovirusantigen
DE69637481D1 (de) Aus immunisierten Xenomäusen stammende menschliche Antikörper gegen IL-8
PH12020500101A1 (en) Novel muscosal adjuvants and delivery systems
BRPI0418317A (pt) vacina de aumento de crescimento à base de epitopo de neutralização
DK1881845T3 (da) Nipah-virusvacciner
IL213189A (en) Vaccine comprising avian influenza antigen, method of vaccinating an animal therewith, dna encoding the antigen and uses thereof
CY1120430T1 (el) Ανασυνδυασμενες cdv συνθεσεις και χρησεις αυτων
EA201391200A1 (ru) Способы и композиции для вакцинации от staphylococcus aureus
WO2007098717A3 (es) Antígenos vacunales quiméricos contra el virus de la peste porcina clásica
WO2007002470A3 (en) Inactivated chimeric vaccines and related methods of use
WO2007098718A8 (es) Antígenos vacunales quiméricos contra el virus de la influenza aviar
NZ731659A (en) Methods of using microneedle vaccine formulations to elicit in animals protective immunity against rabies virus
DK1767639T3 (da) Orale anti-leucocytozoonose-vacciner på basis af transgeniske planter
WO2018066999A3 (en) Chimeric enterovirus virus-like particles
WO2019191586A3 (en) Irradiation-inactivated poliovirus, compositions including the same, and methods of preparation
WO2006062637A3 (en) Influenza vaccination
BRPI0407727A (pt) adjuvante de vacina de linfócito humano
EP3897606A4 (en) ORAL THERAPY WITH 6,8-BISYLTHIOOCTONIC ACID
WO2010033275A3 (en) Orally administerable vaccine for yersinia pestis
RU2002130182A (ru) Способ вакцинопрофилактики полиомиелита на крайнем севере
ECSP12011928A (es) Vacuna de adn contra el virus de la fiebre amarilla
CY1114309T1 (el) Εμβολιο ροταϊου
Bassen My Abortions